Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GSTS Pathology Innovation Academy Demonstrates the Impact of Personalized Medicine

Published: Wednesday, December 18, 2013
Last Updated: Wednesday, December 18, 2013
Bookmark and Share
Second Innovation Academy attracts more than 100 delegates to the Royal Institution of Great Britain.

The second Innovation Academy hosted by GSTS Pathology, attracted more than 100 delegates to the Royal Institution of Great Britain on Friday 6th December 2013.

The theme of the symposium - ‘Personalized medicine: today’s reality, not just a promise for tomorrow’, examined advances in three areas - therapeutic drug monitoring, infectious diseases and transplantation, and oncology - with particular recognition of the impact personalized medicine is making in healthcare.

For more than 200 years the Royal Institution of GB has been home to eminent scientists whose discoveries have helped to shape the modern world, making it a particularly inspiring venue for this Innovation Academy event. Speakers included respected scientists and clinicians from across healthcare, industry and GSTS Pathology.

The Innovation Academy aims to support and showcase scientific innovations developed at GSTS and how they can improve patient care now and in the future.

Fiona Carragher, Deputy Chief Scientific Officer for England, opened the meeting by discussing the many challenges facing today’s heath service and how they can be addressed. “Science will be crucial in this, with research constantly informing new ways of working. While personalized medicine has been in use for a long time - for example INR measurement in anticoagulation therapy - it is clear that genomics and personalized medicine continue to be at the forefront of many new techniques.”

Dr Dominic Harrington, Scientific Director, GSTS Pathology, co-organized the symposium. “Personalized medicine isn’t just a theoretical research idea, but offers practical solutions for tailoring and monitoring therapies in a wide variety of clinical conditions, delivering improvements in patient care today. The Innovation Academy aims to create an environment supportive of innovation, quality and the development of our future scientific leaders. We know that good science equals good medicine.”

As the UK’s leading independent provider of pathology services, GSTS Pathology LLP provides a full suite of clinically led pathology services that make a real difference to patient care.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Higher Frequency of Huntington's Disease Mutations Discovered
University of Aberdeen study shows that the gene change that causes Huntington's disease is much more common than previously thought.
Revealing the Genetic Causes of Bowel Cancer
A landmark study has given the most detailed picture yet of the genetics of bowel cancer — the UK's fourth most common cancer.
Tumor Cells Develop Predictable Characteristics
Scientists have discovered that cancer cells at the edge of a tumor that are close to the surrounding environment are predictably different from the cells within the interior of the tumor.
New Imaging Method Reveals Nanoscale Details about DNA
Enhancement to super-resolution microscopy shows orientation of individual molecules, providing a new window into DNA’s structure and dynamics.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Scoliosis Linked to Disruptions in Spinal Fluid Flow
A new study in zebrafish suggests that irregular fluid flow through the spinal column brought on by gene mutations is linked to a type of scoliosis that can affect humans during adolescence.
A New Tool Brings Personalized Medicine Closer
Scientists from EPFL and ETHZ have developed a powerful tool for exploring and determining the inherent biological differences between individuals, which overcomes a major hurdle for personalized medicine.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!